| Secondary |
| Drug Use For Unknown Indication |
32.2% |
| Product Used For Unknown Indication |
18.4% |
| Depression |
8.4% |
| Weight Loss Diet |
5.5% |
| Suicide Attempt |
4.3% |
| Hypertension |
3.9% |
| Pain |
3.7% |
| Peritoneal Dialysis |
2.9% |
| Bipolar Disorder |
2.7% |
| Hepatitis C |
2.7% |
| Diabetes Mellitus |
2.3% |
| Oropharyngeal Pain |
2.3% |
| Convulsion |
2.0% |
| Asthma |
1.8% |
| Migraine |
1.6% |
| Epilepsy |
1.4% |
| Breast Cancer |
1.0% |
| Juvenile Arthritis |
1.0% |
| Liver Transplant |
1.0% |
| Rheumatoid Arthritis |
1.0% |
|
| Weight Increased |
26.5% |
| Overdose |
9.6% |
| Drug Ineffective |
8.8% |
| Drug Toxicity |
8.1% |
| Suicide Attempt |
5.9% |
| Rash |
4.4% |
| Vomiting |
4.4% |
| Tinnitus |
3.7% |
| Drug Interaction |
2.9% |
| Intentional Overdose |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| Adverse Drug Reaction |
2.2% |
| Adverse Event |
2.2% |
| Drug Eruption |
2.2% |
| Feeling Abnormal |
2.2% |
| Hallucination |
2.2% |
| Malaise |
2.2% |
| Nausea |
2.2% |
| Pruritus |
2.2% |
| Rash Pruritic |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
14.1% |
| Drug Use For Unknown Indication |
12.9% |
| Rheumatoid Arthritis |
11.4% |
| Hypertension |
7.9% |
| Multiple Sclerosis |
6.9% |
| Asthma |
6.4% |
| Depression |
4.7% |
| Psoriasis |
3.8% |
| Pain |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.7% |
| Renal Failure Chronic |
3.2% |
| Breast Cancer |
2.8% |
| Migraine |
2.8% |
| Idiopathic Thrombocytopenic Purpura |
2.7% |
| Diabetes Mellitus |
2.5% |
| Bipolar Disorder |
2.4% |
| Psoriatic Arthropathy |
2.2% |
| Anxiety |
2.0% |
| Blood Cholesterol Increased |
2.0% |
| Premedication |
1.9% |
|
| Vomiting |
9.1% |
| Weight Increased |
7.6% |
| Drug Ineffective |
7.1% |
| Product Quality Issue |
6.7% |
| Therapeutic Response Decreased |
6.4% |
| Weight Decreased |
6.2% |
| Myocardial Infarction |
5.5% |
| Wrong Technique In Drug Usage Process |
5.4% |
| Nausea |
5.0% |
| Tremor |
4.9% |
| Pneumonia |
4.6% |
| Rash |
4.4% |
| Urinary Tract Infection |
3.8% |
| Death |
3.6% |
| Renal Failure |
3.6% |
| Urticaria |
3.5% |
| Injection Site Pain |
3.3% |
| Pyrexia |
3.2% |
| Vision Blurred |
3.2% |
| Headache |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
47.1% |
| Drug Use For Unknown Indication |
8.8% |
| Sleep Disorder Therapy |
8.8% |
| Bipolar Disorder |
5.9% |
| Gastric Disorder |
5.9% |
| Gastrooesophageal Reflux Disease |
5.9% |
| Asthma |
2.9% |
| Fibromyalgia |
2.9% |
| Hypotension |
2.9% |
| Ill-defined Disorder |
2.9% |
| Liver Transplant |
2.9% |
| Rheumatoid Arthritis |
2.9% |
|
| Drug Interaction |
27.3% |
| Amnesia |
9.1% |
| Hypotension |
9.1% |
| Liver Transplant Rejection |
9.1% |
| Nasopharyngitis |
9.1% |
| Rash Macular |
9.1% |
| Renal Disorder |
9.1% |
| Syncope |
9.1% |
| Tachycardia |
9.1% |
|
